Links de acceso rápido
Links para miembros
Categorias
Recolección y frabricación de plasma
Aprende más sobre el proceso de recolección y fabricación de terapias de proteína plasmática
Recursos para pacientes
Explora los recursos de PPTA para pacientes interesados en terapias de proteínas plasmáticas.
Terapias de proteínas plasmáticas
Aprende más sobre las terapias de proteínas plasmáticas y su valor para los pacientes.
Preguntas frecuentes
Acceso a la revista internacional de la industria de las terapias de proteínas plasmáticas.
Concienciación
Aprende más sobre los esfuerzos de la Asociación para garantizar el acceso de los pacientes a terapias.
Acceso a tratamiento
Descubre nuestro registro de problemas de acceso a terapias por región y actividades de PPTA en apoyo a ello.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Oct 28, 2026
Maintaining Immunoglobulins on the Union List of Critical Medicines to Safeguard Patient Access
As the review of the Union List of Critical Medicines (ULCM) approaches its conclusion, the Plasma Protein Therapeutics Association (PPTA) strongly supports maintaining human normal immunoglobulins (IG) on the Union list1 as they are lifesaving, irreplaceable treatments of human origin facing ongoing supply challenges. Maintaining IG on the Union list supports the EU’s broader agenda to strengthen the resilience, security and sustainability of medicines supply as well as safeguard reliable access for patients across Europe.
All
PPTA Statements
https://cdn.prod.website-files.com/6916f1777886bb3b9377a752/6ae22ea3cac65bcf56c49109_FINAL%20PPTA%20statement%20on%20Union%20List%20of%20Critical%20Medicines_28.10.2026.pdf
Oct 28, 2026
Maintaining Immunoglobulins on the Union List of Critical Medicines to Safeguard Patient Access
As the review of the Union List of Critical Medicines (ULCM) approaches its conclusion, the Plasma Protein Therapeutics Association (PPTA) strongly supports maintaining human normal immunoglobulins (IG) on the Union list1 as they are lifesaving, irreplaceable treatments of human origin facing ongoing supply challenges. Maintaining IG on the Union list supports the EU’s broader agenda to strengthen the resilience, security and sustainability of medicines supply as well as safeguard reliable access for patients across Europe.
All
PPTA Statements
https://cdn.prod.website-files.com/6916f1777886bb3b9377a752/6ae22ea3cac65bcf56c49109_FINAL%20PPTA%20statement%20on%20Union%20List%20of%20Critical%20Medicines_28.10.2026.pdf
Oct 21, 2026
Plasma Protein Forum to Convene in Alexandria, VA
All
Press Releases
Oct 21, 2026
Plasma Protein Forum to Convene in Alexandria, VA
All
Press Releases
No hay resultados